Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 29, 2018 12:48 PM 2 min read

Analyst Shows Concerns With 'Impaired LaCroix Sales Growth' For National Beverage

by Jayson Derrick
Follow

The case for turning incrementally bearish on National Beverage Corp. (NASDAQ:FIZZ) remains unchanged heading into the company's fiscal second-quarter earnings print next week, according to Guggenheim.

The Analyst

Guggenheim Partners' Laurent Grandet maintains a Sell rating on National Beverage with a price target lowered from $91 to $83.

The Thesis

Retail sales of National Beverage's LaCroix brand fell 2.6 percent in the final month (October) of the company's fiscal second quarter, Grandet said in a note. This marks a "dramatic deceleration" compared to a 20 percent or more run-rate over the past few months. The loss of momentum likely continued into November, which begs the question if sales can ever fully recover to its prior growth rates.

Grandet said the competitive landscape in the sparkling water category continues to expand from new and established brands. At the same time, innovation from LaCroix remains "underwhelming" and it's likely the brand is reaching its peak distribution which implies a poorer than previously expected future growth trajectory. The new uncertainty warrants a longer-term reduction in sales estimates from 9 percent compounded annual growth through fiscal 2021 to 7 percent.

National Beverage shares are down around 25 percent since September amid concerning headlines, which Grandet said does create a scenario where a competitor might be "tempted" to explore M&A options. It's "very unlikely" a domestic peer would be interested in buying the company and if National Beverage is interested in M&A deals, it must be willing to sell the LaCroix brand in a standalone transaction.

Price Action

Shares of National Beverage were trading lower by 4.6 percent to $84.16 at time of publication.

Related Links:

Imperial Thinks The Top Will Pop On National Beverage, Initiates With Buy

Susquehanna Sticks Up For National Beverage After Pullback

Photo credit: QuoteCatalog, Flickr

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorPrice TargetAnalyst RatingsbeveragesGuggenheim Partners
FIZZ Logo
FIZZNational Beverage Corp
$37.01-%
Overview
FIZZ Logo
FIZZNational Beverage Corp
$37.01-%
Overview
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...